Clinical Trial Update: Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the use of CCTA and MRI to detect unrecognized myocardial scar in asymptomatic patients with type 2 diabetes and subclinical c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Guerbet | Conditions: Type 2 Diabetes Mellitus, Coronary Atherosclerosis | Phase 4 | Status: COMPLETED | Results posted: 2019-05-31